News

Target app to integrate with new Apple Pay

BY Antoinette Alexander

MINNEAPOLIS — Target has announced that it is integrating with the new Apple Pay mobile payments service so shoppers can pay using the Target app from iOS.

“We know mobile is becoming the front door to Target, and we’re focused on creating the best possible mobile experiences for our guests,” stated Jason Goldberger, SVP of Target.com and mobile, in the company’s “A Bullseye View” newsletter. “We’re thrilled to support Apple Pay to streamline how our guests pay in the Target app – this absolutely makes purchasing from Target’s mobile app easier than ever.”

The new Apple Pay is a mobile payments service that will provide an easy way to make purchases from iPhone 6 or iPhone 6 Plus. Shoppers using the Target app from iOS can make purchases with one touch using Touch ID.

Apple Pay will be available in the Target iPhone app in October with a free update to iOS 8, the retailer stated.
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

PhRMA: 44 medicines and vaccines for HIV/AIDS treatment and prevention in development

BY Michael Johnsen

 

WASHINGTON — America’s biopharmaceutical research companies are currently developing 44 medicines and vaccines for HIV/AIDS treatment and prevention, according to the latest Medicines in Development report by the Pharmaceutical Research and Manufacturers of America issued Wednesday. 
 
A second report, a PhRMA-sponsored white paper by Boston Healthcare Associates, “The Value of Innovation in HIV/AIDS Therapy” highlights the progress in HIV/AIDS treatment and its impact on patients with the disease. 
 
Both reports are being released in conjunction with PhRMA’s 2014 Research & Hope Awards, which will honor researchers and patient advocates for their role in improving HIV/AIDS research and care.
 
“Over the past 35 years, HIV/AIDS has gone from a death sentence to a chronic, manageable disease thanks in large part to advances in biopharmaceutical research,” stated PhRMA president and CEO John Castellani. “Despite the progress that has been made, researchers are continuing the fight against HIV/AIDS and, with more than 40 medicines in the pipeline, there is more hope than ever that a cure can be achieved.”
 
Currently, biopharmaceutical companies are focused on improved treatment regimens, more effective therapies and preventive vaccines that are either in clinical trials or awaiting review by the Food and Drug Administration. The 44 medicines and vaccines in the development pipeline include 25 antivirals, 16 vaccines and three cell/gene therapies. 
 
Today, there are 94 active clinical trials for HIV medicines and vaccines in the United States. Of those, 43 have not yet started recruiting patients or have recently begun seeking participants. Therapies being investigated involve attachment inhibitors, gene modification and inducing T-cell responses, among others. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

SpiderTech launches pre-cut kinesiology tape

BY Michael Johnsen

TORONTO — SpiderTech recently announced the launch of its pre-cut kinesiology tape that provides drug-free relief for anyone suffering from minor aches and pain. Each application lasts for up to five days. 
 
SpiderTech works in three ways. First, the tape provides enhanced sensory stimulation which essentially disrupts and diminishes signals of pain. Second, micro-circulatory effects improve fluid dynamics and lymphatic drainage to improve circulation and help in the healing of swelling, bruising and oedema. Finally, if the tape is stretched and applied over muscles in a shortened position, it will serve as support and a mechanical barrier to potentially harmful postures and ranges of motion.  
 
The product is now available in stores nationwide, including 1,000 select Walmart locations, the company reported. 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?